Geneos Wealth Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$893K Sell
423,235
-427,435
-50% -$902K 0.02% 562
2025
Q1
$1.04M Buy
850,670
+461,735
+119% +$563K 0.01% 652
2024
Q4
$502K Buy
388,935
+36,000
+10% +$46.4K 0.02% 589
2024
Q3
$971K Sell
352,935
-40,790
-10% -$112K 0.04% 413
2024
Q2
$890K Sell
393,725
-15,125
-4% -$34.2K 0.04% 383
2024
Q1
$977K Sell
408,850
-3,800
-0.9% -$9.08K 0.04% 355
2023
Q4
$685K Sell
412,650
-4,700
-1% -$7.8K 0.03% 405
2023
Q3
$801K Sell
417,350
-4,300
-1% -$8.26K 0.04% 356
2023
Q2
$607K Sell
421,650
-5,750
-1% -$8.28K 0.03% 429
2023
Q1
$898K Sell
427,400
-7,400
-2% -$15.5K 0.05% 313
2022
Q4
$491K Sell
434,800
-10,400
-2% -$11.8K 0.03% 427
2022
Q3
$725K Sell
445,200
-32,867
-7% -$53.5K 0.05% 313
2022
Q2
$626K Buy
478,067
+3,300
+0.7% +$4.32K 0.03% 438
2022
Q1
$764K Sell
474,767
-6,000
-1% -$9.66K 0.03% 432
2021
Q4
$995K Sell
480,767
-10,600
-2% -$21.9K 0.04% 397
2021
Q3
$1.87M Sell
491,367
-900
-0.2% -$3.42K 0.07% 257
2021
Q2
$1.56M Sell
492,267
-19,339
-4% -$61.3K 0.06% 274
2021
Q1
$2.26M Buy
511,606
+26,000
+5% +$115K 0.06% 272
2020
Q4
$961K Buy
485,606
+448,589
+1,212% +$888K 0.04% 357
2020
Q3
$101K Hold
37,017
0.01% 938
2020
Q2
$108K Sell
37,017
-4,733
-11% -$13.8K 0.01% 887
2020
Q1
$80K Sell
41,750
-2,000
-5% -$3.83K 0.01% 918
2019
Q4
$126K Sell
43,750
-400
-0.9% -$1.15K 0.01% 863
2019
Q3
$160K Sell
44,150
-9,000
-17% -$32.6K 0.01% 725
2019
Q2
$220K Sell
53,150
-2,500
-4% -$10.3K 0.01% 636
2019
Q1
$284K Sell
55,650
-4,000
-7% -$20.4K 0.02% 547
2018
Q4
$224K Hold
59,650
0.02% 564
2018
Q3
$358K Buy
59,650
+47,300
+383% +$284K 0.02% 465
2018
Q2
$78K Sell
12,350
-29,040
-70% -$183K 0.01% 870
2018
Q1
$196K Sell
41,390
-32,095
-44% -$152K 0.02% 546
2017
Q4
$245K Buy
73,485
+4,873
+7% +$16.2K 0.02% 482
2017
Q3
$146K Buy
68,612
+8,000
+13% +$17K 0.01% 602
2017
Q2
$149K Buy
60,612
+4,000
+7% +$9.83K 0.02% 573
2017
Q1
$130K Buy
56,612
+4,000
+8% +$9.19K 0.01% 589
2016
Q4
$51K Buy
52,612
+1,800
+4% +$1.75K 0.01% 833
2016
Q3
$57K Hold
50,812
0.01% 766
2016
Q2
$77K Hold
50,812
0.01% 665
2016
Q1
$73K Buy
+50,812
New +$73K 0.01% 673